プロコラーゲンIIIペプチド
WordNet
- the 9th letter of the Roman alphabet (同)i
- amide combining the amino group of one amino acid with the carboxyl group of another; usually obtained by partial hydrolysis of protein
PrepTutorEJDIC
- 『私は』私が
- iodineの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.
- Kawamura M, Munetsugu Y, Kawasaki S, Onishi K, Onuma Y, Kikuchi M, Tanno K, Kobayashi Y.SourceThe Division of Cardiology, Showa University School of Medicine, Tokyo, Japan.
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.Europace.2012 Dec;14(12):1719-25. doi: 10.1093/europace/eus162. Epub 2012 May 22.
- AIMS: Fibrosis and inflammation may play a significant role in the pathogenesis of atrial fibrillation (AF) recurrence. Type III procollagen-N-peptide (PIIINP) may be related to atrial fibrosis and play a role in predicting the recurrence of AF. We investigated whether PIIINP as a fibrosis marker pr
- PMID 22622138
- Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.
- Hyogo H, Yamagishi SI, Maeda S, Fukami K, Ueda S, Okuda S, Nakahara T, Kimura Y, Ishitobi T, Chayama K.SourceDepartment of Medicine and Molecular Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
- Clinical and experimental medicine.Clin Exp Med.2012 Nov 23. [Epub ahead of print]
- Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined
- PMID 23179302
Japanese Journal
- インターフェロンβが代償期C型肝硬変の門脈圧, 肝線維化マーカーへ及ぼす影響 : 初期成績
- 金沢 秀典,楢原 義之,福田 健,近藤 千紗,張本 滉智,松下 洋子,城所 秀子,片倉 玲樹,厚川 正則,中塚 雄久,坂本 長逸
- 肝臓 52(1), 7-17, 2011-01-25
- 保険適応条件を満たす代償期C型肝硬変10例にIFN-βを1年間投与し,IFN-βが門脈圧,肝線維化マーカー,肝組織像,肝機能へ及ぼす効果を前向きに検討した.6例では治療前に部分的脾動脈塞栓術を必要とした.2例がSVRとなった.門脈圧の指標としたHVPGは17.5±11.8 mmHgから治療終了時12.4±4.3 mmHgへと29%有意に低下した.肝生検像は治療終了時には2例がF4からF3へ,5例で …
- NAID 10029284744
- 活性化トロンビンによる気道リモデリング誘導機序に関する検討(第4回日本アレルギー学会学術大会賞受賞論文)
- 金澤 博,姜 成勲,栩野 吉弘,児玉 豊城,浅井 一久,平田 一人
- アレルギー 58(5), 554-559, 2009-05-30
- … growth factor(VEGF),procollagen type III peptide(P-III-P)濃度を測定した.【結果】喘息群の誘発喀痰中トロンビン活性は,健常群に比較し,有意に高値であった.そして,気道内トロンビン活性とVEGF濃度は有意な相関関係を示した.同様に,トロンビン活性とbFGF濃度との間においても有意な相関関係を認めた.さらに,喘息患者においては,bFGFとP-III-P濃度の間に有 …
- NAID 110007337983
Related Links
- The amino terminal of type III procollagen peptide (P3NP) is an extension peptide that is cleaved and liberated into extracellular fluid and is a serum marker of collagen turnover. Increased levels occur as a consequence of tissue repair and ...
- Collagen is formed initially with propeptides at both ends. In the liver the majority of collagen is either type 1 or type 3. The removal of the propeptides promotes development of collagen fibrils. The propeptides may either be retained in the ...
★リンクテーブル★
[★]
- 英
- procollagen III peptide, P-III-P, PIIIP
[★]
[★]